Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Update

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) saw a large decrease in short interest in August. As of August 14th, there was short interest totaling 30,384 shares, a decrease of 39.2% from the July 30th total of 49,986 shares. Based on an average daily volume of 35,912 shares, the short-interest ratio is presently 0.8 days. Approximately 0.8% of the company’s shares are sold short.

Invesco Pharmaceuticals ETF Trading Down 1.2%

PJP stock traded down $1.47 during trading on Monday, reaching $125.79. 2,892 shares of the stock were exchanged, compared to its average volume of 35,207. The firm’s 50 day moving average is $122.12 and its 200 day moving average is $112.08. Invesco Pharmaceuticals ETF has a twelve month low of $90.01 and a twelve month high of $131.68. The firm has a market cap of $483.03 million, a P/E ratio of 15.59 and a beta of 0.45.

Hedge Funds Weigh In On Invesco Pharmaceuticals ETF

Several institutional investors have recently added to or reduced their stakes in the stock. Fifth Third Bancorp purchased a new position in shares of Invesco Pharmaceuticals ETF during the 1st quarter valued at $36,000. Global Assets Advisory LLC purchased a new position in Invesco Pharmaceuticals ETF during the first quarter valued at approximately $42,000. IFP Advisors Inc increased its holdings in shares of Invesco Pharmaceuticals ETF by 31.3% in the fourth quarter. IFP Advisors Inc now owns 440 shares of the company’s stock worth $46,000 after purchasing an additional 105 shares during the period. International Assets Investment Management LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF in the 4th quarter valued at about $64,000. Finally, Rockefeller Capital Management L.P. grew its stake in Invesco Pharmaceuticals ETF by 20.5% in the 4th quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock worth $129,000 after buying an additional 209 shares in the last quarter.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.